A Comparison of Remifentanil and Dexmedetomidine for Craniotomy Perioperative Hemodynamics and Postoperative Pain
Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
This will be a randomized blinded clinical trial. Patients will be randomized to receive
either a remifentanil or dexmedetomidine infusion for general anesthesia. The anesthesia team
will know the result of randomization at induction. Data will be gathered by research
personnel who will be blinded to the anesthetic method used. Patients will be blinded to the
anesthetic they receive till they are discharged from the PACU when they will have the option
to be unblinded. The Data Safety and -Toxicity Committee will review all serious adverse
events and toxicity reports as well as annual reviews.